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Abstract
The regulation of hematopoietic stem cell (HSC) survival and self-renewal within the bone marrow (BM) niche is not well understood. We therefore investigated global transcriptomic profiling of normal human hematopoietic stem/progenitor cells, revealing that several chemokine ligands (CXCL1-4, CXCL6, CXCL10, CXCL11, CXCL13) were up-regulated in human quiescent CD34 
Introduction
Hematopoietic stem cells (HSC) are responsible for maintenance of the hematopoietic system throughout life and their fate is tightly balanced between self-renewal and differentiation in order to sustain the production of multi-lineage differentiated cells. 1, 2 In mice and humans, most adult HSCs are quiescent, yet remain poised for activation in response to bone marrow (BM) injury or growth factor/interferon stimulation. 3, 4 This balanced state between quiescence, proliferation, and differentiation is tightly controlled by numerous transcriptional networks, modulated by both cell autonomous factors and the surrounding BM niche. 5 Chemokines are a family of chemotactic cytokines which bind to specific 7-transmembrane G-protein-coupled receptors. 6 Chemokines are classified into four main families based on the position of conserved cysteine residues within their N-terminal region; CXC, CC, CX3C and XC chemokines. Chemokines are functionally divided into two groups, homeostatic and inflammatory chemokines. The first are expressed constitutively and are mainly involved in controlling the migration of cells during development and tissue maintenance. Inflammatory chemokines are produced in response to infection or injury and attract inflammatory cells to sites of injury. 7 Chemokines have a variety of roles in development, disease and hematopoiesis, in addition to their role in chemotactic activity on leukocytes. 7, 8 HSC proliferation and survival have been shown to be mediated by members of the chemokine family. 9, 10 Members of the CXC family of chemokines, such as CXCL12 and its receptor CXCR4, play important roles in hematopoietic cell survival, BM localization/retention and mobilization at early stages of life and during adulthood. 11, 12 The role of chemokine ligands and their receptors in HSC fates has not been extensively characterized so far. We have shown that CCL3 is a negative regulator of HSC proliferation with potential for therapeutic application. 13 A previous study has shown that CXCL1 promotes growth and self-renewal in embryonic stem cells, 14 while CXCL4 has been shown to inhibit cell cycle entry in endothelial cells, together with inhibition of DNA synthesis. 15 Importantly, recent data have shown that CXCL4 expressed by megakaryocytes also regulates HSC quiescence. 16 In addition, CXCL12 and CXCR4 play an important role in maintaining HSC quiescence and repopulating activity. 17, 18 HSC survival in vivo is dependent on expression of CXCL12 from endothelial cells and mesenchymal progenitors of the surrounding BM stroma. 19 Finally, it has been shown that chemokines support murine leukemia stem cells in myeloproliferative disorders.
20-22
To identify important regulators of hematopoietic stem/progenitor cell fate decisions, we performed transcriptional profiling of human quiescent and actively dividing stem/progenitor cells and demonstrated that several chemokine ligands (CXCL1-4, CXCL6, CXCL8, CXCL10, CXCL11, CXCL13) were up-regulated in the quiescent fraction. 23 These data suggested that chemokine signalling pathways may be involved in the regulation of HSC fates, such as survival or self-renewal. Here we have further investigated and characterized the requirement for members of the chemokine family in mouse and human hematopoietic stem/progenitor cell survival, focusing on CXCR2 and CXCL4.
Materials and Methods

Reagents
SB225002 was purchased from Merk (Nottingham, UK) and used at the concentrations indicated. All reagent grade chemicals were purchased from Sigma-Aldrich (Poole, UK), unless otherwise stated.
Human samples
The research was approved by West of Scotland Research Ethics Committee 4 and all human participants gave written informed consent. G-CSF-mobilized peripheral blood (PB) stem cell samples were obtained as excess material from normal donors for allogeneic transplantation. 
Cell isolation
Human CD34 + cells were cultured in serum free medium supplemented with a high growth factor cocktail as described previously. 23 Murine BM cells were isolated by crushing whole bones. Cells were filtered after crushing. Mouse BM cells were cultured in IMDM supplemented with 10% FCS, penicillin, streptomycin, L-glutamine and IL-3 (20 ng/ml), IL-6 (20 ng/ml) and SCF (40 ng/ml) (Biolegend, London, UK). Prior to lentiviral transduction, mouse BM samples were enriched for c-Kit + cells using MicroBead (Miltenyi Biotec Inc.).
FACS
Flow cytometry was performed using the FACSCantoII and FACSAria cell sorter (Becton Dickinson, Oxford, UK) and analyzed using FlowJo (Tree Star Incorporation, Oregon, USA).
Murine BM cells were incubated in Fc block prior to antibody staining. Human BM was stained with CD34 (Becton Dickinson, 340667) and CD38 (Becton Dickinson, 551400). Transplantations were monitored using antibodies against CD45.1 and CD45.2 (Becton Dickinson, 558701 and 553772, respectively). 
RNA isolation and real-time PCR
Statistical analysis
Statistical analyzes were performed using the Student's t test. A values of p <0.05 was defined as statistically significant (*). p<0.01 (**) and p<0.001 (***) were taken to be highly statistically significant. Figure 1C) . Taken together, these data suggest that inhibition of chemokine signalling, in particular that of CXCL4 and CXCR2, impairs human stem/progenitor cell function and imply that these factors may be required for survival and maintenance of these cells.
Results
Chemokine ligands are up-regulated in human CD34
Chemokine expression in murine stem and progenitor cells
To investigate a role for the chemokine family in the maintenance of HSCs in their physiological BM microenvironment, parallel murine models were employed. We first In previous examples of genes that are critical for HSC maintenance, an expansion in stem and progenitor cell numbers has often been associated with an alteration in the balance between self-renewal and differentiation, leading to stem cell exhaustion. 35 To determine whether the difference observed in overall HSC frequency in Cxcr2 -/-mice translated into a change in self-renewal capacity, Cxcr2 -/-HSC were investigated in serial transplantation assays ( Figure 5A ). No difference in homing ability was detected between the WT or Cxcr2 
Cxcl4 contributes to the regulation of self-renewal of HSC and progenitor cells
To support the in vitro data on human CXCL4 (Figures 1-3) and to complement the Cxcr2
-/-mouse model we analyzed hematopoiesis in Cxcl4 -/-mice. 36 Previous studies have shown that
Cxcl4
-/-mice exhibited an increased number of HSC and increased HSC proliferation. 16 We observed that Cxcl4 -/-mice showed normal spleen and BM cellularity ( Figure 6A ), while the LSK numbers in BM were increased (*p<0.05) ( Figure 6B ). Furthermore, we found that Cxcl4 -/-mice had a significant decrease in the HSC and an increase in MPP in the BM, but not in the spleen (*p<0.05, ***p<0.001) ( Figure 6C ). Mature cell subsets, including erythroid, granulocytic, B and T cells, were not significantly altered in BM, spleen or thymus of Cxcl4 -/-mice ( Figure 6D-F) . When cell cycle (LSK cells) was analyzed in the WT and
-/-mice, no significant difference was detected between phases (Supplementary Figure   3B) . No changes in apoptosis were detected (Supplementary Figure 3D ).
To investigate changes in self-renewal capacity, a specific Cxcl4 shRNA construct was used to reduce Cxcl4 expression in mouse c-Kit + BM cells using a lentiviral transduction system. Similar to the analysis performed for Cxcr2 -/-, we analyzed the phenotype of Cxcl4 -/-donorderived BM cells after primary transplantation into WT recipient mice, but no difference was seen between the WT and the mutant percentage of donor cells ( Figure 7G ). However, significant decreases were observed in the percentages of donor mutant cells after secondary transplantation in all populations except MPP, when compared to the WT counterparts. In this case, the effect observed in the Cxcl4 -/-HSC before transplantation (significant decrease as compared to WT; Figure 6C ) was maintained after transplantation into a WT microenvironment.
A reduction in
Discussion
Our results indicate that chemokines play an important role in the regulation of HSC survival and self-renewal. HSC homeostasis is a critical process required for the correct functioning of HSC and their progeny. Here we propose that chemokine signalling pathways are involved in the regulation of HSC and cooperate to maintain the quiescent and self-renewing state typical of these cells. Our findings suggest that some chemokines, in particular CXCL4 and the receptor CXCR2, play a key role in the maintenance of the HSC pool. We have observed that
Cxcr2 and Cxcl4 proved to be critical for HSC reconstitution, suggesting a role in selfrenewal.
CXCL1-4, together with CXCL6, CXCL8, CXCL10, CXCL11 and CXCL13, were all significantly up-regulated in the quiescent/primitive fraction of human stem/progenitor cells and, upon modest knock-down of CXCL4, the survival of primitive cells was impaired. It has been shown previously that human hematopoietic CD34 + cells and endothelial cells respond to exogenous CXCL4, with effects on cell viability, adhesion and stem cell expansion. 15, [37] [38] [39] [40] CXCL4 signalling is complex and in certain biological contexts its functions appear to be mediated by the alternatively spliced receptor CXCR3 (CXCR3B) 41 . However, to date, expression of CXCR3B has not been described on human or murine HSC. It has also been suggested that CXCL4 functions may be mediated through another, unnamed receptor/mechanism, with CXCL4 binding to integrin receptors which have indeed been shown to be important for HSC behaviour 42 .
Interactions between CXCL12 and CXCR4 are of key importance for the maintenance of HSCs in humans. [41] [42] [43] AMD3100, a selective CXCR4 antagonist (plerixafor), antagonizes the binding of CXCL12 to CXCR4, leading to a rapid and reversible mobilization of HSC into the peripheral circulation. 44 Currently, plerixafor is used for mobilization of stem cells in patients with non-Hodgkin's lymphoma or multiple myeloma. [45] [46] [47] It has been shown that microenvironmental Cxcl4 derived from megakaryocytes regulates HSC cell cycle activity. Using transgenic inducible diphtheria toxin receptor (IDR) mice (in which megakaryocytes are depleted by IDR expression) crossed with Cxcl4-cre mice, Bruns et al. showed that short-term (7 days) depletion of Cxcl4 led to an increase in HSC proliferation, 4.6-fold increase in HSC numbers and enhanced reconstitution following a single transplantation. However more extended Cxcl4 depletion (for 6 weeks) resulted in an attenuated effect and the authors suggested that the reduced quiescence driven by loss of Cxcl4 may lead in time to HSC exhaustion as previously described 4, 48 . We showed that complete loss of Cxcl4 caused a decrease in HSC numbers, followed by a decrease in selfrenewal capacity detected after secondary transplantation. It is therefore likely that Cxcl4 inhibition does lead at first to a temporary increase in HSC numbers (seen by Bruns et al.) and that this effect is then followed by HSC exhaustion and depletion (due to increased proliferation and differentiation) and by a decrease in self-renewal capacity as we observed in our serial transplantation assay.
By interrogating a previously published transcriptional array we observed that in mice Cxcl4
was the only chemokine ligand up-regulated in the HSC compartment (in house observation 
